Latest Articles

Publication Date
Adverse effects of maternal and paternal body mass index on assisted reproductive techniques outcomes: a time-lapse study.

While obesity has been associated with poor reproductive outcomes, the specific factors affecting gametes remain unclear. Our primary objective was to assess the relationship between a couple's pre-pregnancy body mass …

Published: July 22, 2025, midnight
A Case of Intramural Adenosarcoma With Sarcomatous Overgrowth Associated With Adenomyosis and Endometriosis.

Adenosarcoma is a mixed epithelial and mesenchymal neoplasm composed of a malignant mesenchymal component and a benign Müllerian glandular component. Although the endometrium is the most common primary site, adenosarcoma …

Published: July 21, 2025, midnight
Exploring the therapeutic potential of H1-antihistamines in endometriosis-A gene regulation-based perspective.

Recent studies emphasize the role of immune dysregulation and inflammation in endometriosis (ES). While hormonal therapy remains the primary treatment, emerging research is exploring synergistic approaches that target inflammation. In …

Published: July 17, 2025, midnight
Organon Ends Development of OG-6219 After Endometriosis Trial Fails to Meet Primary Endpoint - MarketScreener

Organon Ends Development of OG-6219 After Endometriosis Trial Fails to Meet Primary Endpoint MarketScreener

Published: July 2, 2025, 12:10 p.m.
Organon ELENA trial misses primary endpoint, to discontinue OG-6219 program - TipRanks

Organon ELENA trial misses primary endpoint, to discontinue OG-6219 program TipRanks

Published: July 2, 2025, 11:54 a.m.
Spontaneous umbilical endometriosis.

Endometriosis is defined as the presence of endometrial tissue (glands and stroma) outside the uterine cavity. Various organs can be affected, including the skin. Umbilical endometriosis is the most common …

Published: June 25, 2025, midnight
DESTINY-Endometrial01 Phase 3 Trial of ENHERTU® Initiated as First-Line Therapy in Patients with HER2 Expressing Primary Advanced or Recurrent Endometrial Cancer - BioSpace

DESTINY-Endometrial01 Phase 3 Trial of ENHERTU® Initiated as First-Line Therapy in Patients with HER2 Expressing Primary Advanced or Recurrent Endometrial Cancer BioSpace

Published: June 9, 2025, 12:43 p.m.
DESTINY-Endometrial01 Phase 3 Trial of ENHERTU® Initiated as First-Line Therapy in Patients with HER2 Expressing Primary Advanced or Recurrent Endometrial Cancer | AZN Stock News - GuruFocus

DESTINY-Endometrial01 Phase 3 Trial of ENHERTU® Initiated as First-Line Therapy in Patients with HER2 Expressing Primary Advanced or Recurrent Endometrial Cancer | AZN Stock News GuruFocus

Published: June 9, 2025, 12:18 p.m.
Daewon Pharm’s uterine fibroid drug meets primary endpoint in P2 trial - koreabiomed.com

Daewon Pharm’s uterine fibroid drug meets primary endpoint in P2 trial koreabiomed.com

Published: May 7, 2025, 6:51 a.m.
Endometriosis presenting as a rectal stricture in a patient with ulcerative colitis and primary sclerosing cholangitis: A case report - Frontiers

Endometriosis presenting as a rectal stricture in a patient with ulcerative colitis and primary sclerosing cholangitis: A case report Frontiers

Published: April 22, 2025, 9:22 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!